フロリダ州における皮膚がんの臨床試験
フロリダ州内の拠点で、皮膚がんに関する15件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Orlando Health Cancer Institute, Orlando
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT05727904Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
- Life Clinical Trials, Coral Springs
- Dermatology Associates of the Palm Beaches, Integri Research at Dermatology Associates, Delray Beach
- University of South Florida, Tampa
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT06585410The Florida ASCENT Study
- University of Florida, Gainesville
被験者募集中
18歳〜100歳 · 全性別 · 2026/07/23更新 · NCT07042243Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/16更新 · NCT06060613Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients
- Integrity Research Clinical Associates, Boca Raton
- Hollywood Dermatology, Hollywood
- Palm Beach Dermatology Group, Palm Beach
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/07/15更新 · NCT06615635Integrated Cancer Repository for Cancer Research
- Florida Hospital Memorial Medical Center, Daytona Beach
- Florida Hospital DeLand, DeLand
- Florida Hospital FISH, Orange City
- 他2件
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/25更新 · NCT04975152A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
- Sylvester Comprehensive Cancer Center, Miami
- Orlando Health Cancer Institute, Orlando
- Moffitt Cancer Center, Tampa
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/06/11更新 · NCT05361174A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- University of Florida, Gainesville
- Mayo Clinic in Florida, Jacksonville
- University of Miami, Miami
被験者募集中観察研究健康なボランティア歓迎
18歳〜100歳 · 全性別 · 2026/05/08更新 · NCT05655494Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
- Mayo Clinic Comprehensive Cancer Center, Jacksonville
- Sylvester Comprehensive Cancer Center, Miami
- Moffitt Cancer Center, Tampa
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/17更新 · NCT06947928Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
- Moffitt Cancer Center, Tampa
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/04/01更新 · NCT05651828Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Florida, Jacksonville
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/12更新 · NCT06349642Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
- Moffitt Cancer Center, Tampa
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/02/05更新 · NCT07222995SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Beta-only IL-2 ImmunoTherapY Study
- Boca Raton Regional Hospital, Boca Raton
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。